Takeaway
- A multifaceted intervention program for patients with early-stage NSCLC that used race-specific data and real-time warnings of missed appointments or milestones from electronic health records monitored by a nurse navigator significantly reduced racial disparities in treatment rates.
Why this matters
- Studies show that black patients with NSCLC undergo curative treatment less often than white patients.
Study design
- Treatment rates of patients with early-stage NSCLC in an intervention program (n=360) were compared with retrospective (n=2841) and concurrent (n=597) control patients.
- Funding: National Cancer Institute; American Cancer Society.
Key results
- 31.7% of the intervention group, 15.9% of retrospective control patients, and 13.2% of concurrent control patients were black.
- Overall treatment rate was higher in the intervention group vs the retrospective and concurrent groups, regardless of race (96% vs 76% vs 83%, respectively; P<.001 for all>
- Overall treatment rates were higher with intervention for all patients:
- Intervention group: 96% for both blacks and whites.
- Retrospective group: 69% for blacks, 78% for whites.
- Concurrent group: 79% for blacks, 84% for whites.
- Receipt of surgery or radiation was lower for blacks in the retrospective group (aOR, 0.66; P=.001), but no racial disparity was seen in the intervention group (aOR for blacks, 2.1; P=.39).
Limitations
- Black patients were intentionally oversampled in the intervention group.
Only healthcare professionals with a Univadis account have access to this article.
You have reached your limit of complementary articles
Free Sign Up Available exclusively to healthcare professionalsLogin to
account
Don’t have an account? Get started